Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Multiple Myeloma 56Precursor Cell Lymphoblastic Leukemia-Lymphoma 16Burkitt Lymphoma 12Lymphoma, Mantle-Cell 6Lymphoma, Large B-Cell, Diffuse 6Immunoglobulin Light-chain Amyloidosis 6Vomiting 5Recurrence 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Nausea 5Leukemia, Myeloid, Acute 5Leukemia 5Neoplasms, Plasma Cell 4Neoplasm Metastasis 4Lymphoma, Non-Hodgkin 4Lymphoma 4Hodgkin Disease 4Breast Neoplasms 4Blast Crisis 4Smoldering Multiple Myeloma 3Neoplasms 3Myelodysplastic Syndromes 3Leukemia, Myelomonocytic, Chronic 3Brain Neoplasms 3Sarcoma 2Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Plasmacytoma 2Ovarian Neoplasms 2Neuroblastoma 2Lymphoma, Follicular 2

Interventions

Rituximab 15Cyclophosphamide 15Peripheral Blood Stem Cell Transplantation 14fludarabine phosphate 11Whole-Body Irradiation 11Mycophenolic Acid 8Etoposide 8Methotrexate 7Filgrastim 7Cyclosporine 7Lenalidomide 6Dexamethasone 6Busulfan 6Tacrolimus 5Radiotherapy 5Cytarabine 5Carboplatin 5Thiotepa 4Melphalan 4Transplantation 3Therapeutics 3Granulocyte Colony-Stimulating Factor 3Flow Cytometry 3Calcium Dobesilate 3Bortezomib 3Antilymphocyte Serum 3pegfilgrastim 2etoposide phosphate 2Psychiatric Rehabilitation 2Polymerase Chain Reaction 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Intraocular Lymphoma × dexamethasone acetate × Clear all
NCT01722305 2019-07-22

Pomalidomide and Dexamethasone in Treating Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma or Newly Diagnosed or Relapsed or Refractory Intraocular Lymphoma

Mayo Clinic

Phase 1 Completed
29 enrolled
Lymphoid

Burkitt Lymphoma, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Intraocular Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡